Dudediligence.

Emergent BioSolutions Inc

EBSNYSE · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$44,797

2 notices · 6,000 sh

Jun 11 to Oct 4

Reported ·

$1,394,323

13 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

8 of 13 reported sales carry the 10b5-1 box. Together they are 0.28% of the shares on issue.

PLANNED · FORM 144Jun 11 to Oct 4REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-10-01: PAUL WILLIAMS, Form 1442026-07-01: PAUL WILLIAMS, Form 1442025-10-07: Glessner Coleen, sold2025-11-07: Dayal Sujata Tyagi, sold2025-11-10: DeGolyer Donald W, sold2025-12-05: Richard Ronald, sold2026-04-01: Williams Paul Anthony, sold2026-04-30: Katkin Keith, sold2026-05-01: Dayal Sujata Tyagi, sold2026-05-01: DeGolyer Donald W, sold2026-05-01: Zoon Kathryn C, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-10-01PAUL WILLIAMS, SVP, Products Business$19,592
3,000 shplan 2025-11-14Form 4s on file end Jun 23144 ↗
2026-07-01PAUL WILLIAMS, SVP, Products Business$25,205
3,000 shplan 2025-11-14Form 4s on file end Jun 23144 ↗